Basel Medical Group Ltd ( (BMGL) ) has released a notification of late filing.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Basel Medical Group Ltd has announced a delay in filing its Form 20-F (Yearly Report) for the fiscal year ending June 30, 2025. The primary reason for this delay is the additional time required to finalize its consolidated financial statements and for the completion of audit procedures by its independent registered public accounting firm. The company expects to file the report no later than fifteen days after the original due date of October 31, 2025. Basel Medical Group Ltd has indicated that there will be no significant changes in its financial results compared to the previous fiscal year. The notification was signed by Dr. Darren Yen Feng Chhoa, the Chief Executive Officer, highlighting the company’s commitment to compliance and transparency.
More about Basel Medical Group Ltd
Average Trading Volume: 131,133
Technical Sentiment Signal: Strong Sell
See more data about BMGL stock on TipRanks’ Stock Analysis page.